Skip to main content
. 2023 Aug 5;12(1):2243169. doi: 10.1080/2162402X.2023.2243169

Figure 1.

Figure 1.

Predictive biomarkers of response and/or survival in patients receiving immune checkpoint immunotherapy. MSI: microsatellite instability, TMB: Tumor mutational burden, GES: gene expression signature, TILs: tumor-infiltrating lymphocytes, TLS: Tertiary lymphoid structures, Immunoscore-IC: digital pathology of CD8+/PD-L1+ cells, Immunoscore: digital pathology of CD3+/CD8+ cells.